Delhi High Court seeks response from govt, NPPA on Glenmark's plea

Delhi High Court hears Glenmark Pharma's petition against NPPA's pricing order for anti-diabetic drugs, claiming arbitrary pricing and seeking exemption due to DCGI approval.

Related Keywords

India ,Delhi ,Rohan Sharma ,Remogliflozin Etabonate ,Debmalya Banerjee ,Justice Subramonium Prasad ,Arvind Nigam ,Delhi High Court ,Ministry Of Chemicals ,National Pharmaceutical Pricing Authority ,Glenmark Pharma ,Drugs Controller General ,Subramonium Prasad ,Metformin Hydrochloride ,Cosmetics Rules ,Patents Act ,Abbott Healthcare ,Sun Pharma Labs ,Diabetic Drug ,Drug Pricing ,Dcgi ,Nppa ,Lupin ,